Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ODELL, ROBERT

NPI: 1013957026 · LAS VEGAS, NV 89117 · Pain Medicine (Anesthesiology) Physician · NPI assigned 06/07/2006

$130K
Total Medicaid Paid
2,827
Total Claims
1,661
Beneficiaries
14
Codes Billed
2018-01
First Month
2020-11
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,559 $60K
2019 839 $51K
2020 429 $19K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg 382 212 $53K
97032 930 193 $28K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 336 320 $22K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 187 157 $9K
64635 57 30 $7K
64483 37 35 $4K
64636 55 17 $2K
64493 25 24 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 74 69 $1K
82962 348 280 $411.47
64494 12 12 $396.16
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 17 16 $368.97
36416 352 284 $314.64
80305 15 12 $88.88